Axsome Therapeutics, Inc. ($AXSM)
Filing Information
| Accession Number | 0001193125-26-006695 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
418,242
Total Value
$24,999,717.80
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 5, 2026 | Exercise/Conversion | 78,703 | $8.02 | $631,198.06 | 85,932 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 5, 2026 | Sale | 78,703 | $171.28 | $13,480,249.84 | 7,229 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 6, 2026 | Exercise/Conversion | 29,450 | $8.02 | $236,189.00 | 36,679 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 6, 2026 | Sale | 29,450 | $172.33 | $5,075,118.50 | 7,229 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 7, 2026 | Exercise/Conversion | 31,261 | $8.02 | $250,713.22 | 38,490 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 7, 2026 | Sale | 31,261 | $170.38 | $5,326,249.18 | 7,229 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 5, 2026 | Exercise/Conversion | 78,703 | $0.00 | $0.00 | 93,121 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 6, 2026 | Exercise/Conversion | 29,450 | $0.00 | $0.00 | 63,671 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 7, 2026 | Exercise/Conversion | 31,261 | $0.00 | $0.00 | 32,410 | Direct | โ | View Details |